Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of ZR2 Bioenergy
Quarter-by-quarter operating performance
| Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses + | 0.06 | 0.05 | 0.07 | 0.06 | 0.09 | 0.28 | 0.20 | 0.13 | 0.26 | 0.07 |
| Operating Profit | -0.06 | -0.05 | -0.07 | -0.06 | -0.09 | -0.28 | -0.20 | -0.13 | -0.26 | -0.07 |
| OPM % | ||||||||||
| Other Income + | 0.07 | 0.02 | 0.02 | 0.05 | 0.06 | 0.03 | 0.45 | 0.46 | 0.55 | 0.42 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.15 |
| Profit before tax | 0.01 | -0.03 | -0.05 | -0.01 | -0.03 | -0.27 | 0.23 | 0.31 | 0.28 | 0.20 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.83% | 0.00% | 0.00% | -15.00% |
| Net Profit + | 0.00 | -0.03 | -0.05 | -0.01 | -0.03 | -0.26 | 0.11 | 0.31 | 0.27 | 0.23 |
| EPS in Rs | 0.00 | -0.19 | -0.31 | -0.06 | -0.19 | -0.73 | 0.31 | 0.87 | 0.76 | 0.64 |
Financials of ZR2 Bioenergy
Annual income statement trend
| Mar 2022 | Mar 2025 | TTM | |
|---|---|---|---|
| Sales + | 1.16 | 1.49 | 0.00 |
| Expenses + | 1.11 | 1.87 | 0.66 |
| Operating Profit | 0.05 | -0.38 | -0.66 |
| OPM % | 4.31% | -25.50% | |
| Other Income + | 0.27 | 0.64 | 1.88 |
| Interest | 0.00 | 0.01 | 0.00 |
| Depreciation | 0.00 | 0.04 | 0.20 |
| Profit before tax | 0.32 | 0.21 | 1.02 |
| Tax % | -21.88% | 52.38% | |
| Net Profit + | 0.39 | 0.09 | 0.92 |
| EPS in Rs | 2.44 | 0.25 | 2.58 |
| Dividend Payout % | 0.00% | 0.00% |
Financials of ZR2 Bioenergy
Capital structure and asset base
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 0.36 | 0.36 |
| Reserves | 138.99 | 139.56 |
| Borrowings + | 0.00 | 0.00 |
| Other Liabilities + | 0.15 | 0.56 |
| Total Liabilities | 139.50 | 140.48 |
| Fixed Assets + | 0.50 | 0.48 |
| CWIP | 118.96 | 119.63 |
| Investments | 0.00 | 0.00 |
| Other Assets + | 20.04 | 20.37 |
| Total Assets | 139.50 | 140.48 |
Financials of ZR2 Bioenergy
Operating, investing and financing cash movement
| Mar 2022 | Mar 2025 | |
|---|---|---|
| Cash from Operating Activity + | 0.91 | 31.05 |
| Cash from Investing Activity + | 0.19 | -116.66 |
| Cash from Financing Activity + | 0.00 | 100.39 |
| Net Cash Flow | 1.10 | 14.78 |
| Free Cash Flow | 0.91 | -88.44 |
| CFO/OP | 1,780% | -8,171% |
Financials of ZR2 Bioenergy
Working capital efficiency and return ratios
| Mar 2022 | Mar 2025 | |
|---|---|---|
| Debtor Days | 4.90 | |
| Inventory Days | 0.00 | |
| Days Payable | ||
| Cash Conversion Cycle | 4.90 | |
| Working Capital Days | 161.68 | |
| ROCE % |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…